Inventor · disambiguated record
Alla Danilkovitch
Also filed as: DANILKOVITCH ALLA
35 granted patents·58 pending applications·186 citations·filing 2007–2025
97Inventor score
Top patents by PatentIndex Score
93 records- 0196US11510947B2Methods of manufacture of immunocompatible amniotic membrane productsOSIRIS THERAPEUTICS INC·Filed 2020·Granted Nov 29, 2022·5 cites·14 claims
- 0296US10550369B2Enhanced MSC preparationMESOBLAST INT SARL·Filed 2018·Granted Feb 4, 2020·19 cites·20 claims
- 0396US9956248B2Methods of manufacture of therapeutic products comprising vitalized placental dispersionsOSIRIS THERAPEUTICS INC·Filed 2013·Granted May 1, 2018·24 cites·13 claims
- 0495US11638725B2Methods of manufacture of immunocompatible chorionic membrane productsOSIRIS THERAPEUTICS INC·Filed 2019·Granted May 2, 2023·2 cites·14 claims
- 0595US10646519B2Methods of manufacture of therapeutic products comprising vitalized placental dispersionsOSIRIS THERAPEUTICS INC·Filed 2018·Granted May 12, 2020·6 cites·19 claims
- 0695US10272116B2Immunocompatible amniotic membrane productsOSIRIS THERAPEUTICS INC·Filed 2014·Granted Apr 30, 2019·16 cites·20 claims
- 0795US9963678B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2015·Granted May 8, 2018·17 cites·11 claims
- 0894US10576104B2Methods of manufacture of immunocompatible amniotic membrane productsOSIRIS THERAPEUTICS INC·Filed 2013·Granted Mar 3, 2020·15 cites·17 claims
- 0994US9828586B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2013·Granted Nov 28, 2017·20 cites·19 claims
- 1093US11821004B2Mesenchymal stem cells expressing TNF-α receptorsMESOBLAST INT SARL·Filed 2020·Granted Nov 21, 2023·3 cites·13 claims
- 1193US2025064857A1Methods of manufacture of immunocompatible chorionic membrane productsOSIRIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1293US2024189361A1Immunocompatible amniotic membrane productsOSIRIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1393US2024189362A1Immunocompatible amniotic membrane productsOSIRIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1491US10265344B2Immunocompatible chorionic membrane productsOSIRIS THERAPEUTICS INC·Filed 2014·Granted Apr 23, 2019·7 cites·25 claims
- 1590US12109241B2Methods of manufacture of immunocompatible chorionic membrane productsOSIRIS THERAPEUTICS INC·Filed 2023·Granted Oct 8, 2024·0 cites·19 claims
- 1690US8486695B2Mesenchymal stem cells expressing TNF-alpha receptorsDANILKOVITCH ALLA·Filed 2012·Granted Jul 16, 2013·33 cites·5 claims
- 1790US2024261335A1Therapeutic products comprising vitalized placental dispersionsOSIRIS THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1888US12318408B2Methods of manufacture of therapeutic products comprising vitalized placental dispersionsOSIRIS THERAPEUTICS INC·Filed 2023·Granted Jun 3, 2025·0 cites·18 claims
- 1988US10874763B2Porated cartilage productsOSIRIS THERAPEUTICS INC·Filed 2014·Granted Dec 29, 2020·3 cites·17 claims
- 2088US2023128936A1Methods of manufacture of immunocompatible amniotic membrane productsOSIRIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2187US10258650B2Methods of manufacture of immunocompatible chorionic membrane productsOSIRIS THERAPEUTICS INC·Filed 2013·Granted Apr 16, 2019·4 cites·16 claims
- 2286US2025262245A1Methods of manufacture of therapeutic products comprising vitalized placental dispersionsOSIRIS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2385US12410405B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2023·Granted Sep 9, 2025·0 cites·16 claims
- 2485US11708560B2Enhanced MSC preparationsMESOBLAST INT SARL·Filed 2019·Granted Jul 25, 2023·2 cites·7 claims
- 2585US11590172B2Immunocompatible chorionic membrane productsOSIRIS THERAPEUTICS INC·Filed 2019·Granted Feb 28, 2023·0 cites·11 claims
- 2685US11406735B2Methods of manufacturing cartilage productsOSIRIS THERAPEUTICS INC·Filed 2014·Granted Aug 9, 2022·2 cites·19 claims
- 2785US11207353B2Immunocompatible amniotic membrane productsOSIRIS THERAPEUTICS INC·Filed 2019·Granted Dec 28, 2021·0 cites·15 claims
- 2884US2024301356A1Mesenchymal stem cells expressing tnf-alpha receptorsMESOBLAST INT SARL·Filed 2023·Application pending·0 cites
- 2983US2021369784A1Immunocompatible amniotic membrane productsOSIRIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3082US10279974B2Support and packaging for membranesOSIRIS THERAPEUTICS INC·Filed 2015·Granted May 7, 2019·4 cites·28 claims
- 3182US2022331485A1Disrupted cartilage productsOSIRIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3281US12268797B2Non-cultured, partially digested, cryopreserved cartilage productOSIRIS THERAPEUTICS INC·Filed 2022·Granted Apr 8, 2025·0 cites·26 claims
- 3381US2025281673A1Bone repair product and methods of use thereofOSIRIS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 3479US10729809B2Bone repair product and methods of use thereofOSIRIS THERAPEUTICS INC·Filed 2015·Granted Aug 4, 2020·2 cites·25 claims
- 3578US11590173B2Methods of manufacture of therapeutic products comprising vitalized placental dispersionsOSIRIS THERAPEUTICS INC·Filed 2020·Granted Feb 28, 2023·0 cites·12 claims
- 3678US2024261471A1Adipose compositions and methods of use thereofBRITECYTE INC·Filed 2024·Application pending·0 cites
- 3777US12343446B2Bone repair product and methods of use thereofOSIRIS THERAPEUTICS INC·Filed 2022·Granted Jul 1, 2025·0 cites·25 claims
- 3875US11986498B2Therapeutic products comprising vitalized placental dispersionsOSIRIS THERAPEUTICS INC·Filed 2013·Granted May 21, 2024·0 cites·4 claims
- 3974US2020171096A1Viable lyophilized compositions derived from human tissues and methods of making the sameOSIRIS THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4073US2022202876A1Viable lyophilized compositions derived from human tissues and methods of making the sameOSIRIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4173US2023063467A1Adipose compositions and methods of use thereofBRITECYTE INC·Filed 2022·Application pending·0 cites
- 4272US10994913B2Support and packaging for membranesOSIRIS THERAPEUTICS INC·Filed 2019·Granted May 4, 2021·1 cites·31 claims
- 4371US10624931B2Umbilical tissue compositions and methods of useOSIRIS THERAPEUTICS INC·Filed 2016·Granted Apr 21, 2020·1 cites·14 claims
- 4468US2021023268A1Bone repair product and methods of use thereofOSIRIS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4566US2022016180A1Umbilical tissue compositions and methods of useOSIRIS THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 4665US11464809B2Umbilical tissue compositions and methods of useOSIRIS THERAPEUTICS INC·Filed 2020·Granted Oct 11, 2022·0 cites·14 claims
- 4765US11413373B2Disrupted cartilage productsOSIRIS THERAPEUTICS INC·Filed 2014·Granted Aug 16, 2022·0 cites·18 claims
- 4864US2010098672A1Use of mesenchymal stem cells for treating genetic diseases and disordersVARNEY TIMOTHY·Filed 2009·Application pending·0 cites
- 4963US2008286249A1Use of mesenchymal stem cells for treating genetic diseases and disordersVARNEY TIMOTHY R·Filed 2008·Application pending·0 cites
- 5063US2014322180A1Use of mesenchymal stem cells for completely repopulating host tissueMESOBLAST INTERNAT SÁRL·Filed 2014·Application pending·0 cites
Showing the top 50 of 93 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Alla Danilkovitch files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →